Sorafenib and triptolide loaded cancer cell-platelet hybrid membrane-camouflaged liquid crystalline lipid nanoparticles for the treatment of hepatocellular carcinoma

In addition to early detection, early diagnosis, and early surgery, it is of great significance to use new strategies for the treatment of hepatocellular carcinoma (HCC). Studies showed that the combination of sorafenib (SFN) and triptolide (TPL) could reduce the clinical dose of SFN and maintain go...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhe, Yang, Gang, Han, Lu, Wang, Rong, Gong, Chunai, Yuan, Yongfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576878/
https://www.ncbi.nlm.nih.gov/pubmed/34749742
http://dx.doi.org/10.1186/s12951-021-01095-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576878/
https://www.ncbi.nlm.nih.gov/pubmed/34749742
http://dx.doi.org/10.1186/s12951-021-01095-w

Ejemplares similares